+157.2%
MRNA vs ELAN
-1.5%
+158.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | ELAN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.4% | +4.0% | +4.2% |
| 7D | -1.1% | -5.4% | +4.3% | +3.9% |
| 30D | +126.1% | +4.7% | +121.4% | +133.4% |
| 3M | +190.0% | -3.7% | +193.7% | +203.8% |
| 6M | +157.2% | -1.2% | +158.4% | +162.3% |
| All | +157.2% | -1.5% | +158.8% | +162.3% |
Cumulative growth
Daily Returns
Daily percentage return beside ELAN.
Daily Out/Under-Performance
Portfolio return minus ELAN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ELAN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded ELAN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling